Phioanh L. Nghiemphu

Author

University of California, Los Angeles ORCID

Also Known As

Douglas Ney, J. M. Bruner, L. P. Meyer, P L Nghiemphu, P Leia Nghiemphu, P. L. Nghiemphu, P. Leia Nghiemphu, P. Nghiemphu, P.L. Nghiemphu, PhiOanh [Leia] NghiemPhu

335

Publications

11.8K

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles Samueli Institute Memorial Sloan Kettering Cancer Center Dana-Farber Cancer Institute University of California, San Francisco

About

Phioanh L. Nghiemphu is an author at University of California, Los Angeles specializing in medicine, glioma, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	46	4.6K
2	Health Sciences	12	12	1.1K
3	Engineering	11	11	453
4	Cell Biology	8	8	637
5	Social Sciences	1	1	104

Phioanh L. Nghiemphu

117

Publications

11.4K

Citations

H-Index

Page 1

	Year	Citations
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla, Nature Medicine Neuro-oncologyNeoadjuvant Anti-pd-1 ImmunotherapyTumor ImmunologyCancer ImmunosurveillanceGlioma	2019	1.3K
Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma Tim Cloughesy, Koji Yoshimoto, Phioanh L. Nghiemphu, PLoS Medicine	2008	585
Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme Albert Lai, Anh Tran, Phioanh L. Nghiemphu, Journal of Clinical Oncology	2010	451
Evidence for Sequenced Molecular Evolution of <i>IDH1</i> Mutant Glioblastoma From a Distinct Cell of Origin Albert Lai, Samir Kharbanda, Whitney B. Pope, Journal of Clinical Oncology	2011	438
Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain Jeffrey C. Lee, Igor Vivanco, Rameen Beroukhim, PLoS Medicine	2006	362
Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors Igor Vivanco, H. Ian Robins, Daniel Rohle, Cancer Discovery	2012	336
Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment Whitney B. Pope, Grace Hyun J. Kim, Jing Huo, Radiology	2009	317
Relationship between Tumor Enhancement, Edema,<i>IDH1</i>Mutational Status,<i>MGMT</i>Promoter Methylation, and Survival in Glioblastoma Jose Carrillo, Albert Lai, Phioanh L. Nghiemphu, American Journal of Neuroradiology	2012	295
MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy Whitney B. Pope, Albert Lai, Phioanh L. Nghiemphu, Neurology Pediatric Brain TumorsOncologic ImagingContrast-enhancing Tumor ShrankPet-mriRecurrent Gliomas	2006	272
Bevacizumab and chemotherapy for recurrent glioblastoma Phioanh L. Nghiemphu, W. Liu, Yurim Lee, Neurology	2009	233

Page 1